Clinical Trials

231 enrolled

Rectal Neoplasms

NCT07429318 2026-02-24

GC/GEJC

Active not recruiting

300 enrolled

Phase 1/2 Active not recruiting

Locally Advanced Gastric/Gastroesophageal Junction Adenocarcinoma

NCT04868877 2026-02-19

Phase 1/2 Study Evaluating MCLA-129, a Human Anti-EGFR, Anti-c-MET Bispecific Antibody, in Advanced NSCLC and Other Solid Tumors, Alone and in Combination

194 enrolled

GastrointestinalHead & Neck

Squamous Cell Carcinoma of Head and Neck, Esophageal Squamous Cell Carcinoma, Head and Neck Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

NCT07339488 2026-01-14

ILDR-03

43 enrolled

Esophageal Squamous Cell Carcinoma

NCT03599752 2026-01-09

Chemotherapy and/or Metastasectomy in Treating Patients With Metastatic Colorectal Adenocarcinoma With Lung Metastases

40 enrolled

Colorectal Neoplasms

NCT07306663 2025-12-29

ESO-Nanjing7

242 enrolled

Esophageal Neoplasms

NCT05111626 2025-12-15

FORTITUDE-102

515 enrolled

Phase 1/2 Active not recruiting

Stomach Neoplasms

NCT04888312 2025-10-08

OPTIMIZE-1

94 enrolled

Phase 1 Active not recruiting

Pancreatic Neoplasms

NCT04046133 2025-08-05

CORINTH

52 enrolled

Phase 1 Active not recruiting

Anus Neoplasms

NCT05704985 2025-05-29

Evaluating Safety and Biomarkers Using DK210 (EGFR) for Locally Advanced or Metastatic EGFR+ Tumors

39 enrolled

DermatologicGastrointestinalGenitourinaryHead & NeckThoracic

Carcinoma, Non-Small-Cell Lung, Head and Neck Neoplasms, Kidney Neoplasms, Neoplasms, Pancreatic Neoplasms, Skin Neoplasms, Colorectal Neoplasms

NCT06922279 2025-05-11

SOCRATE

Phase NA Active not recruiting

108 enrolled

Gastroesophageal Cancer (GC)

NCT06946420 2025-04-27

SENECA

108 enrolled

Radiation Therapy

NCT02843191 2024-12-27

Consolidation Chemotherapy for Locally Advanced Mid or Low Rectal Cancer After Neoadjuvant Concurrent Chemoradiotherapy

358 enrolled

Rectal Neoplasms

NCT06667050 2024-10-31

CAPOX Plus Sintilimab and Bevacizumab Biosimilar (IBI305) for Neoadjuvant Treatment of Locally Advanced Gastric Cancer

58 enrolled

Gastric Adenocarcinoma

NCT03018418 2024-09-19

Proton Therapy in Reducing Toxicity in Anal Cancer

14 enrolled 14 charts

Anus Neoplasms

NCT04230759 2024-09-19

RADIANCE

180 enrolled

Anus Neoplasms

NCT03443856 2024-01-05

VESTIGE

197 enrolled

Phase 1/2 Active not recruiting

Gastric and Esophagogastric Junction Adenocarcinoma

NCT03544736 2023-03-22

Safety and Feasibility of Irradiation and Nivolumab in Esophageal Cancer (INEC)

30 enrolled